Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 9, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

February 28, 2025

Conditions
Short Bowel SyndromeInfection, Bacterial
Interventions
DRUG

Amoxicillin

Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally

DRUG

Levofloxacin

Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally

DRUG

Ofloxacin

Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally

DRUG

Sulfamethoxazole trimethoprim

Each patient will receive the proper antibiotic to treat the infection, first intravenously, then orally

Trial Locations (1)

54500

RECRUITING

CHRU Nancy, Vandœuvre-lès-Nancy

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Société Francophone Nutrition Clinique et Métabolisme

OTHER

collaborator

FIlière des Maladies rares Abdomino-THOraciques

UNKNOWN

collaborator

Fresenius Kabi

INDUSTRY

lead

Central Hospital, Nancy, France

OTHER